Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Cambrex Corporation    CBM

CAMBREX CORPORATION (CBM)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/16/2017 11/17/2017 11/20/2017 11/21/2017 11/22/2017 Date
48.3(c) 48.1(c) 48.1(c) 49.55(c) 49.05(c) Last
770 958 513 115 339 272 332 114 322 176 Volume
+2.01% -0.41% 0.00% +3.01% -1.01% Change
More quotes
Financials ($)
Sales 2017 535 M
EBIT 2017 142 M
Net income 2017 98,8 M
Finance 2017 118 M
Yield 2017 -
Sales 2018 538 M
EBIT 2018 128 M
Net income 2018 89,8 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 16,74
P/E ratio 2018 18,47
Capi. / Sales2017 2,81x
Capi. / Sales2018 3,01x
Capitalization 1 622 M
More Financials
Company
Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics.It supplies to innovator and generic pharmaceutical companies.Its products include generic and branded APIs, controlled... 
Sector
Pharmaceuticals
Calendar
02/07Earnings Release
More about the company
Surperformance© ratings of Cambrex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on CAMBREX CORPORATION
11/14 CAMBREX : wins API Development Award at CPhI Worldwide
11/09 CAMBREX : Invests in New Small Scale Capacity at Its Charles City, Iowa Facility
11/09 CAMBREX : WINS API DEVELOPMENT AWARD AT CPhI WORLDWIDE FOR SECOND CONSECUTIVE YE..
11/08 CAMBREX : Invests in New Small Scale Capacity at Its Charles City, Iowa Facility
11/07 CAMBREX : posts 3Q profit
11/07 CAMBREX : Management's Discussion and Analysis of Financial Condition and Result..
11/07 CAMBREX CORP : Results of Operations and Financial Condition, Financial Statemen..
11/07 Cambrex Reports Third Quarter 2017 Financial Results
11/07 CAMBREX CORPORATION : to Host Earnings Call
11/06 CAMBREX : to Present at the Stephens Fall Investment Conference
More news
Sector news : Pharmaceuticals - NEC
03:46p FTSE gets sterling boost, land purchase threat dents housebuilders
09:50a U.S. FDA approves first two-drug HIV regimen in win for GSK
11/21 Brexit gets real for drugmakers as regulator moves to Amsterdam
11/21 Exclusive - Prescient messages about Indian companies circulate in WhatsApp g..
11/20 ASTRAZENECA : EU drugs agency move to Amsterdam minimizes likely staff losses
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
11/16 RECRO PHARMACEUTICALS : Prescriptions For Pain Are A Prescription For Gain
11/09 Cambrex's (CBM) CEO Steven Klosk on Q3 2017 Results - Earnings Call Transcrip..
11/07 Cambrex beats by $0.07, beats on revenue
11/06 Notable earnings before Tuesday?s open
10/25 Cambrex a new short at Lakewood Capital
Chart CAMBREX CORPORATION
Duration : Period :
Cambrex Corporation Technical Analysis Chart | CBM | US1320111073 | 4-Traders
Technical analysis trends CAMBREX CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 59,8 $
Spread / Average Target 21%
EPS Revisions
Managers
NameTitle
Steven M. Klosk President, Chief Executive Officer & Director
Shlomo Yanai Non-Executive Chairman
Shawn P. Cavanagh Chief Operating Officer & Executive Vice President
Tom Vadaketh Chief Financial Officer & Vice President
Peter G. Tombros Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CAMBREX CORPORATION-10.84%1 622
JOHNSON & JOHNSON19.78%371 653
NOVARTIS11.20%220 090
ROCHE HOLDING LTD.-1.55%212 522
PFIZER8.90%211 844
MERCK AND COMPANY-6.23%148 014